GlassScriptPhysician profile
John Mcconnell
NPI 1376566349
$5,286.07
in general payments reported to CMS, 2019-2025
13 companies · $38.00 in 2025
The $38.00 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,667 · 2020: $19.65 · 2021: $2,092 · 2022: $234 · 2023: $208 · 2024: $27.70 · 2025: $38.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $273.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $4,528.17 | 2019-2021 | |
| Smith+Nephew, INC. | $481.66 | 2019-2023 | Bone Anchors With Arthroscopic Delivery System, Acufex, Microraptor |
| Bioventus LLC | $44.02 | 2019 | |
| Depuy Synthes Sales INC. | $38.55 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $38.00 | 2025 | |
| Acumed LLC | $27.70 | 2024 | Inframe Implant, Nanophix Implant |
| Ethicon US, LLC | $26.19 | 2019 | |
| Fidia Pharma USA INC. | $24.00 | 2023 | Hymovis |
| Avanos Medical | $18.16 | 2019 | |
| Abbott Laboratories | $16.41 | 2019 | |
| Daiichi Sankyo INC. | $16.23 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $14.74 | 2019 | |
| Integra Lifesciences Corporation | $12.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Mcconnell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.